Lineage Cell Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Lineage Cell Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2018 to Q3 2024.
  • Lineage Cell Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $2.62M.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.62M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.84M Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.13M Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.81M -$967K -25.6% Dec 31, 2023 10-Q 2024-11-14
Q4 2022 $3.78M Dec 31, 2022 10-K 2024-03-07
Q2 2022 $2.05M Jun 30, 2022 10-Q 2022-08-11
Q4 2020 $242K -$590K -70.9% Dec 31, 2020 10-K 2021-03-11
Q4 2019 $832K -$1.17M -58.4% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $5.19M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $4.75M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $4.94M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $2M Jan 2, 2019 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.